益气散结方联合常规疗法治疗结直肠腺瘤术后临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R735.34

基金项目:


Clinical Study on Yiqi Sanjie Prescription Combined with Routine Therapy for Patient After Surgery of Colorectal Adenomas
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察益气散结方联合常规疗法治疗结直肠腺瘤术后患者的效果。方法:选取109 例行结直 肠腺瘤内镜下切除术的脾虚湿热兼血瘀证患者作为研究对象,采用随机数字表法分为对照组54 例和观察组 55 例,2 组均予术后止血、抗感染、营养支持等常规疗法治疗8 周,观察组加服益气散结方治疗8 周。于术后 治疗前、治疗8 周后评定临床症状评分,检测细胞因子[白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)、 C-反应蛋白(CRP)]、肿瘤标记物[癌胚抗原(CEA)、糖链抗原199(Ca199)、糖链抗原50(Ca50)];记录 2 组患者治疗期间的不良反应发生情况;治疗8 周后评定临床疗效;于术后3 个月、6 个月复查、统计腺瘤复 发情况,术后6 个月检查腺瘤生长情况。结果:治疗8 周后,观察组临床疗效优于对照组(P<0.05)。2 组 TNF-α、IL-6、CRP、CEA、Ca199、Ca50 水平均较治疗前下降(P<0.05),观察组6 项指标值均低于对照 组(P<0.05)。2 组腹痛、大便形状、大便次数、黏液便评分均较治疗前减少(P<0.05),观察组4 项评分值 均低于对照组(P<0.05)。2 组患者在治疗期间均未发生严重不良反应。观察组术后3 个月、术后6 个月的腺 瘤复发率均低于对照组(P<0.05)。观察组术后6 个月的腺瘤数少于对照组,腺瘤最大直径、腺瘤平均直径均 小于对照组,差异均有统计学意义(P<0.05)。结论:在常规疗法基础上加用益气散结方治疗结直肠腺瘤术后 脾虚湿热兼血瘀证患者效果明显,能够有效减轻炎症反应,抑制肿瘤细胞的增殖和转移,改善临床症状,降低 腺瘤复发率,安全性高。

    Abstract:

    Abstract:Objective:To observe the effect of Yiqi Sanjie Prescription combined with routine therapy on patients after surgery of colorectal adenomas. Methods: A total of 109 cases of patients who had the syndrome of damp- heat due to spleen deficiency and blood stasis and received endoscopic resection of colorectal adenoma were selected as the study objects, and were divided into the control group and the observation group according to the random number table method, with 54 and 55 cases in each group respectively. Both groups were treated with routine therapies such as postoperative hemostasis, antiinfection, and nutritional support for 8 weeks, and the observation group was additionally given the oral administration with Yiqi Sanjie Prescription for 8 weeks. Before treatment and after 8 weeks of treatment, the clinical symptom scores were evaluated,the cytokines including interleukin- 6 (IL-6),tumor necrosis factor- α (TNF- α),and C- reactive protein (CRP),and tumor markers including carcinoembryonic antigen (CEA),carbohydrate antigen 199 (Ca199) and carbohydrate antigen 50 (Ca50) were detected. The incidence of adverse reactions during treatment was recorded in the two groups. After 8 weeks of treatment, the clinical effects were evaluated. The recurrence of adenoma at 3 and 6 months after the surgery,and the growth of adenoma during the first 6 months after the surgery were rechecked and counted. Results:After 8 weeks of treatment,the clinical effect in the observation group was better than that in the control group (P<0.05). The levels of TNF- α,CRP,CEA,Ca199,and Ca50 in the two groups were decreased when compared with those before treatment (P<0.05),and the 6 indexes in the observation group were lower than those in the control group (P<0.05). The scores of abdominal pain,stool characteristics,defecation frequency, and stool with mucus in the two groups were decreased when compared with those before treatment (P<0.05),and the 4 scores in the observation group were lower than those in the control group (P<0.05). There was no serious adverse reaction in the two groups during treatment. The recurrence rates of adenoma in the observation group at 3 months and 6 months after the surgery were lower than those in the control group (P<0.05). The number of adenomas in the observation group was less than that in the control group 6 months after the surgery,and the maximum diameter and average diameter of adenomas in the observation group were smaller than those in the control group, differences being significant (P< 0.05). Conclusion:For patients who had the syndrome of damp- heat due to spleen deficiency and blood stasis and received endoscopic resection of colorectal adenoma,Yiqi Sanjie Prescription based on routine therapy has a significant effect,and can effectively relieve inflammatory responses,inhibit the proliferation and metastasis of tumor cells, improve clinical symptoms, and reduce the recurrence rate of adenoma, with high safety.

    参考文献
    相似文献
    引证文献
引用本文

贾彦超,冀春丽,张立明,刘俊杰,席作武.益气散结方联合常规疗法治疗结直肠腺瘤术后临床研究[J].新中医,2023,55(6):121-126

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-03-28
  • 出版日期:
文章二维码